Fibrosis is a condition with globally high unmet medical need, and as such is a highly active area of academic and pharmaceutical research covering multiple treatment targets, organs, tissues and therapeutic approaches. Anti-fibrotic Drug Discovery is a single source reference for the latest drug-discovery approaches to tackle fibrosis in various tissues, comprehensively covering recent success and future perspectives on emerging therapeutic intervention points. This book is ideal for practitioners in fibrosis drug discovery and research as well as clinicians specialising in liver, kidney, heart and lung disease, in which fibrosis plays a key role in pathology.